Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
9.64
+0.91 (10.42%)
At close: Jun 2, 2026, 4:00 PM EDT
9.54
-0.10 (-1.04%)
After-hours: Jun 2, 2026, 7:59 PM EDT
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $101.67 million as of June 2, 2026. Its market cap has increased by 236.04% in one year.
Market Cap
101.67M
Enterprise Value
39.09M
1-Year Change
236.04%
Ranking
Category
Stock Price
$9.64
Market Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $101.67M, a decrease of -95.94%. That is a compound annual growth rate of -41.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 92.07M | -57.56% |
| Dec 31, 2025 | 216.95M | 213.30% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Castle Biosciences | 636.02M |
| Fulgent Genetics | 513.77M |
| Myriad Genetics | 404.24M |
| Prenetics Global | 343.13M |
| Insight Molecular Diagnostics | 198.89M |
| Biodesix | 154.36M |
| Exagen | 129.26M |
| FONAR | 125.20M |